Company Overview
CHINA PHARMA HOLDINGS, INC.
CPHIRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
5M
2024 FY
Net Income
-5M
2024 FY
Shares Outstanding
17M
2024 FY
EPS
-0.27USD
2024 FY
Company Information
SIC Code
2834
CIK Code
1106644
Exchange
NYSE
Location
CN